Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 14Carcinoma, Non-Small-Cell Lung 14Brain Neoplasms 12Sarcoma 7Meningioma 6Glioma 6Pancreatic Neoplasms 5Lung Neoplasms 5Esophageal Neoplasms 5Breast Neoplasms 5Squamous Cell Carcinoma of Head and Neck 4Neoplasms 4Glioblastoma 4Carcinoma, Hepatocellular 4Solid Tumor, Adult 3Rhabdomyosarcoma 3Radiation Injuries 3Liver Neoplasms 3Head and Neck Neoplasms 3Chondrosarcoma 3Uterine Cervical Neoplasms 2Thymus Neoplasms 2Solid Tumor 2Prostate Adenocarcinoma 2Pituitary Neoplasms 2Pinealoma 2Osteosarcoma 2Oligodendroglioma 2Nerve Sheath Neoplasms 2Nasopharyngeal Carcinoma 2

Interventions

Specimen Handling 2nedaplatin 1X-Rays 1Relaxation Therapy 1Protons 1Proton Therapy 1Platinum Compounds 1Physical Therapy Modalities 1Pemetrexed 1Paclitaxel 1Docetaxel 1Cisplatin 1Carboplatin 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Resectable Lung Non-Small Cell Carcinoma × Proton Therapy × Clear all
NCT06008730 2025-11-10

Proton Beam Radiation Therapy After Treatment for Resected N2 Non-Small Cell Lung Cancer

Emory University

Phase 2 Recruiting
20 enrolled

Resectable Lung Non-Small Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡